Literature DB >> 14582902

The pharmacoepidemiology of COPD: recent advances and methodological discussion.

P Burney1, S Suissa, J B Soriano, W M Vollmer, G Viegi, S D Sullivan, L M Fabbri, D D Sin, P Ernst, D Coultas, J Bourbeau, D W Mapel, K Weiss, T McLaughlin, D Price, M C J M Sturkenboom, R Taylor, G W Hagan.   

Abstract

Mesh：

Year:  2003        PMID： 14582902

Source DB:  PubMed          Journal:  Eur Respir J Suppl        ISSN： 0904-1850


× No keyword cloud information.
  11 in total

Review 1.  COPD exacerbations. 4: Prevention.

Authors:  S Scott; P Walker; P M A Calverley
Journal:  Thorax       Date:  2006-05       Impact factor: 9.139

Review 2.  Inhaled corticosteroids in chronic obstructive pulmonary disease: is there a clinical benefit?

Authors:  S F Paul Man; Don D Sin
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Assessing treatment effects of inhaled corticosteroids on medical expenses and exacerbations among COPD patients: longitudinal analysis of managed care claims.

Authors:  Manabu Akazawa; Sally C Stearns; Andrea K Biddle
Journal:  Health Serv Res       Date:  2008-07-29       Impact factor: 3.402

Review 4.  Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review.

Authors:  Kokuvi Atsou; Christos Chouaid; Gilles Hejblum
Journal:  BMC Med       Date:  2011-01-18       Impact factor: 8.775

5.  COPD uncovered: an international survey on the impact of chronic obstructive pulmonary disease [COPD] on a working age population.

Authors:  Monica J Fletcher; Jane Upton; Judith Taylor-Fishwick; Sonia A Buist; Christine Jenkins; John Hutton; Neil Barnes; Thys Van Der Molen; John W Walsh; Paul Jones; Samantha Walker
Journal:  BMC Public Health       Date:  2011-08-01       Impact factor: 3.295

Review 6.  Advanced Role of Neutrophils in Common Respiratory Diseases.

Authors:  Jinping Liu; Zhiqiang Pang; Guoqiang Wang; Xuewa Guan; Keyong Fang; Ziyan Wang; Fang Wang
Journal:  J Immunol Res       Date:  2017-05-15       Impact factor: 4.818

7.  Periodontal status and lung function decline in the community: the Hisayama study.

Authors:  Kenji Takeuchi; Koichiro Matsumoto; Michiko Furuta; Satoru Fukuyama; Toru Takeshita; Hiroaki Ogata; Shino Suma; Yukie Shibata; Yoshihiro Shimazaki; Jun Hata; Toshiharu Ninomiya; Yoichi Nakanishi; Hiromasa Inoue; Yoshihisa Yamashita
Journal:  Sci Rep       Date:  2018-09-06       Impact factor: 4.379

8.  Prevalence of chronic obstructive pulmonary disease and pattern of comorbidities in a general population.

Authors:  Caterina Anecchino; Elisa Rossi; Caterina Fanizza; Marisa De Rosa; Gianni Tognoni; Marilena Romero
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

9.  Outcomes and costs of treating chronic obstructive pulmonary disease with inhaled fixed combinations: the Italian perspective of the PATHOS study.

Authors:  Alessandro Roggeri; Claudio Micheletto; Daniela Paola Roggeri
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-06-05

10.  Trends in health care resource utilization and pharmacological management of COPD in Taiwan from 2004 to 2010.

Authors:  Ying-Huang Tsai; Tsung-Ming Yang; Chieh-Mo Lin; Shu-Yi Huang; Yu-Wen Wen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.